BioNick™ DNA Labeling System
Product Image
Invitrogen™

BioNick™ DNA Labeling System

The BioNick™ DNA Labeling System is ideal for generating biotinylated DNA probes by nick translation optimized for use in non-radioactiveRead more
Have Questions?
Catalog NumberQuantity
1824701550 Reactions
Catalog number 18247015
Price (CNY)
7,758.00
Each
Add to cart
Quantity:
50 Reactions
Price (CNY)
7,758.00
Each
Add to cart
The BioNick™ DNA Labeling System is ideal for generating biotinylated DNA probes by nick translation optimized for use in non-radioactive in situ hybridizations. These probes can also be used in Southern or northern blots, plaque lifts, colony hybridizations, and dot blot hybridizations. Using the BioNick™ DNA Labeling System:

• DNA is labeled with biotin-14-dATP, producing probe sizes from 50 to 500 bp
• One reaction labels 1 μg of template DNA
For Research Use Only. Not for use in diagnostic procedures.
Specifications
Includes Label or DyeYes
Labeling MethodDirect Labeling
Product LineBioNick
Product TypeDNA Labeling System
Quantity50 Reactions
Shipping ConditionApproved for shipment on Wet or Dry Ice
Detection MethodBiotin-based
Final Product TypeProbes (Labeled DNA)
Labeling TargetDNA (General)
Label or DyeBiotin
Unit SizeEach
Contents & Storage
The BioNick™ DNA Labeling System includes 10X dNTP mix containing biotin-14-dATP, 10X enzyme mix containing DNA Polymerase I and DNase I, control DNA, stop buffer, and distilled water. Store at -20°C. Guaranteed stable for 6 months when properly stored.

Frequently asked questions (FAQs)

What is the difference between the BioNick system and the BioPrime system?

The BioNick Labeling System generates biotinylated DNA probes by nick translation. These probes range from 50 to 500 bases. One reaction labels 1 µg of DNA. The BioPrime Labeling System generates 50-500 ng of biotinylated DNA from 25 ng template DNA by random priming. The probe size ranges from 50 to 700 bases, with a significant portion of the probe being less than 200 bases. See Mackey, J., Rashtchian, A. (1992) FOCUS 14, p.21.

Citations & References (4)

Citations & References
Abstract
Loss of the SKI proto-oncogene in individuals affected with 1p36 deletion syndrome is predicted by strain-dependent defects in Ski-/- mice.
Authors: Colmenares Clemencia; Heilstedt Heidi A; Shaffer Lisa G; Schwartz Stuart; Berk Michael; Murray Jeffrey C; Stavnezer Ed;
Journal:Nat Genet
PubMed ID:11731796
'Experiments involving overexpression of Ski have suggested that this gene is involved in neural tube development and muscle differentiation. In agreement with these findings, Ski-/- mice display a cranial neural tube defect that results in exencephaly and a marked reduction in skeletal muscle mass. Here we show that the penetrance ... More
Cloning and characterization of a family of proteins associated with Mpl.
Authors: Meunier Caroline; Bordereaux Didier; Porteu Francoise; Gisselbrecht Sylvie; Chrétien Stany; Courtois Geneviève;
Journal:J Biol Chem
PubMed ID:11784712
'Thrombopoietin (TPO) controls the formation of megakaryocytes and platelets from hematopoietic stem cells via activation of the c-Mpl receptor and multiple downstream signal transduction pathways. We used two-hybrid screening to identify new proteins that interacted with the cytoplasmic domain of Mpl, and we found a new family of proteins designated ... More
Endothelial induction of fgl2 contributes to thrombosis during acute vascular xenograft rejection.
Authors:Ghanekar A, Mendicino M, Liu H, He W, Liu M, Zhong R, Phillips MJ, Levy GA, Grant DR,
Journal:J Immunol
PubMed ID:15100314
Thrombosis is a prominent feature of acute vascular rejection (AVR), the current barrier to survival of pig-to-primate xenografts. Fibrinogen-like protein 2 (fgl2/fibroleukin) is an inducible prothrombinase that plays an important role in the pathogenesis of fibrin deposition during viral hepatitis and cytokine-induced fetal loss. We hypothesized that induction of fgl2 ... More
Structural and functional genomics of the CPT1B gene for muscle-type carnitine palmitoyltransferase I in mammals.
Authors: van der Leij Feike R; Cox Keith B; Jackson Vicky N; Huijkman Nicolette C A; Bartelds Beatrijs; Kuipers Jaap R G; Dijkhuizen Trijnie; Terpstra Peter; Wood Philip A; Zammit Victor A; Price Nigel T;
Journal:J Biol Chem
PubMed ID:12015320
Muscle-type carnitine palmitoyltransferase I (M-CPT I) is a key enzyme in the control of beta-oxidation of long-chain fatty acids in the heart and skeletal muscle. Because knowledge of the mammalian genes encoding M-CPT I may aid in studies of disturbed energy metabolism, we obtained new genomic and cDNA data for ... More